Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial.
Pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), known for its role in migraine pathogenesis, has been identified as a novel drug target. Given the clinical parallels betwee...